It was a little more than a year ago that Danaher announced the acquisition of Life Technologies’ MS business and MDS Analytical Technologies, including Molecular Devices (see IBO 9/15/10). The acquisition introduced a new player into the MS market and expanded Danaher’s business in the life science research instrument market. With 2009 revenues in excess […]
Although fiscal 2010 figures related to American Recovery and Reinvestment Act (ARRA) funding are not yet available, fiscal 2009 figures have been released for the research-oriented agencies that were major recipients (see IBO 2/28/09). The National Institutes of Health (NIH) reported that fiscal 2009 ARRA-obligated, ARRA-funded awards totaled $1,354 million. An August report released by […]
Prior to the end of the US federal government’s fiscal 2010 on September 30, President Obama signed a continuing resolution to extend federal government funding at current levels until December 3. The 12 fiscal 2011 budget bills have yet to pass Congress. The final budget and its passage is dependent on the outcome of November‘s […]
In a development that is expected to further the use of MS for proteomics research and biomarker analysis, the Institute for Systems Biology and the Swiss Federal Institute of Technology have announced that they have generated gold-standard reference mass spectra for each of the human genome’s 20,300 protein-encoding genes. This completes the first phase of […]
Second-quarter revenues for IBO’s Lab Equipment/Consumables Sales Index grew 4.6%, 4.7% excluding currency, to $4,183.68 million. While most companies reported increased revenue growth due to the general economic recovery, certain businesses were still negatively impacted by capital restrains. Operating profits for the Index climbed 13.7% to $709.32 million, and adjusted operating margins improved 140 basis […]
Spending by US universities on science and engineering (S&E) R&D grew 5.8% to $54,935 million in fiscal 2009 (ended September 30, 2009), according to a survey of 711 institutions by the National Science Foundation (NSF). Such spending accelerated last year, compared with fiscal 2008, when it grew 4.9%. Adjusted for inflation, fiscal 2009 expenditures rose […]
Although the macroeconomic outlook remains positive, signs of slowing worldwide growth have increased uncertainty among businesses. This uncertainty is reflected in the latest IBO Business Climate Survey. Instrument and lab product sales are expected to be stable, but the fallout from the global recession continues to affect growth. Also, intellectual property concerns related to doing […]
US equity markets soared in September following positive corporate results, renewed M&A activity, lower unemployment claims, increased consumer spending and better-than-expected manufacturing data. In addition, on September 20, the National Bureau of Economic Research officially confirmed that the US recession ended in June 2009, further arousing investors’ optimism. As a result, the Dow Jones Industrial […]
The second of IBO’s biannual new laboratory roundup primarily focuses on chemical, consumer and government research. The table on page 3 highlights new labs in the energy, food and pharmaceutical industries. Many companies are expanding their facilities in Asia in the hopes of strengthening their presence and increasing sales. Merck opened its Material Research Center […]
In IBO’s second part of its annual examination of new and existing litigation among analytical instrument and lab product companies (see IBO 4/30/10), we report on new suits involving third-generation sequencing technologies, as well as one case that may be headed for the Supreme Court. Settlements With the trial set to begin in November in […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
